Micro- and Nanotechnology related to Biological sciences
Hungarian and Israeli biotech companies teamed up to tackle Crohn’s, an intractable inflammatory bowel disease that affects five million people worldwide. Its causes are uncertain. There is no foolproof cure and poor public understanding of the pain and chronic suffering it causes. But things are looking up thanks to the work of the Eureka PIP-4-CD team.
Saica, a family-owned Spanish paper and packaging business, developed a cost-effective, ‘green’ solution to meet growing demand for white-grade top-coated paper (testliners). Thanks to EUREKA pre-market support, that technology is now being applied at a new production plant.
To integrate new digital currencies, such as Bitcoin, into global financial systems requires that checks and balances be put in place to ensure adherence to local laws and regulations and protect consumers from fraud while maintaining privacy. This is where the Blockchain PISC project comes in.